Diphtheria
219
3
7
192
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
107 trials with published results (49%)
Research Maturity
192 completed trials (88% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
1.4%
3 terminated out of 219 trials
98.5%
+12.0% vs benchmark
70%
153 trials in Phase 3/4
56%
107 of 192 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 192 completed trials
Clinical Trials (219)
A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
Safety Monitoring of Boostagen® Vaccine in Thailand
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
Confirmatory Study of BK1310 in Healthy Infants
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
PFAS Exposure and Immune Response to Vaccination in Adults
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Sero-epidemiological Survey of England in 2019/2020 - COVID-19
A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults
Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS